Skip to content

A multi-center registry evaluating the safety of carotid artery stenting in symptomatic and asymptomatic carotid artery stenosis patients in Japan

A multi-center registry evaluating the safety of carotid artery stenting in symptomatic and asymptomatic carotid artery stenosis patients in Japan - CASSIS Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007922
Enrollment
400
Registered
2012-05-10
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid artery stenosis

Interventions

None listed

Sponsors

A study group for therapy of carotid artery stenosis
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients for whom one of the following definitions apply: a. Presenting neurological symptoms and stenosis of 50% or greater in either the common or internal carotid artery as confirmed by ultrasound or angiography. b. Presenting no neurological symptoms but stenosis of 80% or greater in either the common or internal carotid artery as confirmed by ultrasound or angiography. Neurological symptoms refer to cerebral or retinal transient ischemic attack (TIA) or ischemic stroke. Stenosis is to be measured with the ESCT method when using ultrasound, and the NASCET method when measured by angiography. 2) Patients judged to be appropriate candidates for CAS by the attending physician 3) Patients who have given informed written consent to participate in the study and are 20 years or older at the time of consent.

Exclusion criteria

Exclusion criteria: 4) Patients who have undergone CAS, CEA, PCI, EVT or vascular bypass within the past 30 days. 5) Patients currently enrolled or planning to enroll in clinical trial(s) that could affect the outcome of this study. 6) Patients for whom a follow up examination 30 days post-CAS would be difficult.

Design outcomes

Primary

MeasureTime frame
Incidence of major adverse events (AMI, stroke and death) occurring within 48 hours, 30 days and 12 months post-procedure. Stroke symptoms which resolve within 24 hours will be excluded.

Countries

Japan

Contacts

Public ContactHiroyoshi Yokoi

A study group for therapy of carotid artery stenosis CASSIS Registry Office

cassis.registry@gmail.com092-832-1100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026